Identification and validation of a cancer-associated fibroblasts-related scoring system to predict prognosis and immune landscape in hepatocellular carcinoma through integrated analysis of single-cell and bulk RNA-sequencing
Figure 13.Drug sensitivity analysis based on the CAFRss. (A–G) Box plots display the drugs with different IC50 values across the risk subgroups.